136 related articles for article (PubMed ID: 19820025)
1. Predicting recurrence of nonfunctioning pituitary adenomas.
Noh TW; Jeong HJ; Lee MK; Kim TS; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2009 Nov; 94(11):4406-13. PubMed ID: 19820025
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
3. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
4. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
5. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M
J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100
[TBL] [Abstract][Full Text] [Related]
6. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma.
Gopalan R; Schlesinger D; Vance ML; Laws E; Sheehan J
Neurosurgery; 2011 Aug; 69(2):284-93. PubMed ID: 21792138
[TBL] [Abstract][Full Text] [Related]
8. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
[TBL] [Abstract][Full Text] [Related]
9. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
10. [The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas].
Iwai Y; Yamanaka K; Yoshioka K; Yoshimura M; Honda Y; Matsusaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2005 Aug; 33(8):777-83. PubMed ID: 16095207
[TBL] [Abstract][Full Text] [Related]
11. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
12. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
13. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma.
Dekkers OM; Pereira AM; Roelfsema F; Voormolen JH; Neelis KJ; Schroijen MA; Smit JW; Romijn JA
J Clin Endocrinol Metab; 2006 May; 91(5):1796-801. PubMed ID: 16507632
[TBL] [Abstract][Full Text] [Related]
14. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
[TBL] [Abstract][Full Text] [Related]
15. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.
Gejman R; Swearingen B; Hedley-Whyte ET
Hum Pathol; 2008 May; 39(5):758-66. PubMed ID: 18439942
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients.
Brochier S; Galland F; Kujas M; Parker F; Gaillard S; Raftopoulos C; Young J; Alexopoulou O; Maiter D; Chanson P
Eur J Endocrinol; 2010 Aug; 163(2):193-200. PubMed ID: 20460423
[TBL] [Abstract][Full Text] [Related]
18. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas.
Dekkers OM; Pereira AM; Romijn JA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3717-26. PubMed ID: 18682516
[TBL] [Abstract][Full Text] [Related]
19. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
